Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PIM2 Antikörper

PIM2 Reaktivität: Human ELISA, IP Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN5701191
  • Target Alle PIM2 Antikörper anzeigen
    PIM2 (Proto-Oncogene Pim-2 (Serine Threonine Kinase) (PIM2))
    Reaktivität
    • 41
    • 6
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 36
    • 4
    • 2
    • 1
    Kaninchen
    Klonalität
    • 38
    • 5
    Polyklonal
    Konjugat
    • 28
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser PIM2 Antikörper ist unkonjugiert
    Applikation
    • 29
    • 21
    • 17
    • 15
    • 5
    • 5
    • 5
    • 2
    • 1
    • 1
    ELISA, Immunoprecipitation (IP)
    Immunogen
    pim-2 oncogene
    Isotyp
    IgG
    Top Product
    Discover our top product PIM2 Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Buffer
    PBS with 0.02 % sodium azide and 50 % glycerol  pH 7.3
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Avoid repeated freeze / thaw cycles.
    Lagerung
    -20 °C
    Haltbarkeit
    12 months
  • Target
    PIM2 (Proto-Oncogene Pim-2 (Serine Threonine Kinase) (PIM2))
    Andere Bezeichnung
    PIM2 (PIM2 Produkte)
    Synonyme
    cb1068 antikoerper, fj47b05 antikoerper, pim2 antikoerper, wu:fj47b05 antikoerper, DXCch3 antikoerper, Pim-2 antikoerper, Pim-2 proto-oncogene, serine/threonine kinase antikoerper, proviral integration site 2 antikoerper, pim2 antikoerper, PIM2 antikoerper, Pim2 antikoerper
    Hintergrund
    Synonyms: Background:Proto-oncogene with serine/threonine kinase activity involved in cell survival and cell proliferation. Exerts its oncogenic activity through: the regulation of MYC transcriptional activity, the regulation of cell cycle progression, the regulation of cap-dependent protein translation and through survival signaling by phosphorylation of a pro-apoptotic protein, BAD. Phosphorylation of MYC leads to an increase of MYC protein stability and thereby an increase transcriptional activity. The stabilization of MYC exerted by PIM2 might explain partly the strong synergism between these 2 oncogenes in tumorigenesis. Regulates cap-dependent protein translation in a mammalian target of rapamycin complex 1(mTORC1)-independent manner and in parallel to the PI3K-Akt pathway. Mediates survival signaling through phosphorylation of BAD, which induces release of the anti-apoptotic protein Bcl-X(L)/BCL2L1. Promotes cell survival in response to a variety of proliferative signals via positive regulation of the I-kappa-B kinase/NF-kappa-B cascade, this process requires phosphorylation of MAP3K8/COT. Promotes growth factor-independent proliferation by phosphorylation of cell cycle factors such as CDKN1A and CDKN1B. Involved in the positive regulation of chondrocyte survival and autophagy in the epiphyseal growth plate.
    Gen-ID
    11040
    UniProt
    Q9P1W9
Sie sind hier:
Kundenservice